Riliprubart is an immunoglobulin G4 humanized antibody that is designed to selectively inhibit activated C1s in the classical complement pathway of the innate immune system.

Benlysta is supplied as a single-dose prefilled autoinjector or prefilled syringe containing 200mg/mL of belimumab for SC use. The prefilled syringe has not been studied in pediatric patients aged ...

HealthDay News — Electroconvulsive therapy (ECT) shows a significant protective effect against suicide and overall mortality in people with depression, according to a review published online June 12 ...

HealthDay News — US drug overdose deaths (DODs) started declining in 2023, with a faster decline for opioid-related versus stimulant-related DOD rates, according to a study published online June 12 in ...

The Food and Drug Administration (FDA) has approved Harliku ™ (nitisinone) for the reduction of urine homogentisic acid (HGA) in adult patients with alkaptonuria.